Fig. 4.

Prognostic relevance of the patients` individual sHGF dynamics. Patients’ dynamic curves showing the progression of sHGF levels in the time between primary diagnosis and after the completion of chemotherapy. (A) Example of a patient with a high AUC and (B) the Kaplan–Meier analyses comparing progression‐free survival and OS (n _{(PFS and OS)} = 56) of ovarian cancer patients with a high AUC value vs. patients with a low AUC value. P‐values, HR, and 95%CI were calculated, as described in Materials and methods section.